Celebrity Lyme Drives Unproven Therapies

Celebrity disclosures about Lyme disease amplify public demand for explanations and cures, which private clinics and ancillary labs meet by marketing extended antibiotic courses, niche diagnostics and high‑cost experimental treatments despite weak or contested evidence. That dynamic turns medical uncertainty into a commercial opportunity and a cultural narrative that is hard to correct with data alone. — If unchecked, this dynamic shifts healthcare resources, raises risk of harm from unnecessary or unsafe treatments, and hardens polarized debates over evidence and patient experience.